|
1
|
Abdulazeez S Sheik: Diabetes treatment: A
rapid review of the current and future scope of stem cell research.
Saudi Pharm J. 23:333–340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scully T: Diabetes in numbers. Nature.
485:S2–S3. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sikorska D, Pawlaczyk K, Olewicz-Gawlik A,
Czepulis N, Posnik B, Baum E, Wanic-Kossowska M, Lindholm B and Oko
A: The importance of residual renal function in peritoneal
dialysis. Int Urol Nephrol. 48:2101–2108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abbasakoor NO, Healy ML, O'Shea D, Maguire
D, Muldoon C, Sheahan K and O'Toole D: Metastatic insulinoma in a
patient with type 2 diabetes mellitus: Case report and review of
the literature. Int J Endocrinol. 2011:1240782011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Diabetes Association, . Diagnosis
and classification of diabetes mellitus. Diabetes care. 37:(Suppl
1). S81–S90. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prentice KJ, Luu L, Allister EM, Liu Y,
Jun LS, Sloop KW, Hardy AB, Wei L, Jia W, Fantus IG, et al: The
furan fatty acid metabolite CMPF is elevated in diabetes and
induces β cell dysfunction. Cell Metab. 19:653–666. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rutter GA, Pullen TJ, Hodson DJ and
Martinez-Sanchez A: Pancreatic β-cell identity, glucose sensing and
the control of insulin secretion. Biochem J. 466:203–218. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang S, Yang Z, Gao Y, Li Q, Su Y, Wang Y,
Zhang Y, Man H and Liu H: Pyruvate kinase, muscle isoform 2
promotes proliferation and insulin secretion of pancreatic β-cells
via activating Wnt/CTNNB1 signaling. Int J Clin Exp Pathol.
8:14441–14448. 2015.PubMed/NCBI
|
|
9
|
Tangvarasittichai S: Oxidative stress,
insulin resistance, dyslipidemia and type 2 diabetes mellitus.
World J Diabetes. 6:456–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Del Prato S, Bianchi C and Marchetti P:
beta-cell function and anti-diabetic pharmacotherapy. Diabetes
Metab Res Rev. 23:518–527. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vetere A, Choudhary A, Burns SM and Wagner
BK: Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug
Discov. 13:278–289. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Santulli G, Pagano G, Sardu C, Xie W,
Reiken S, D'Ascia SL, Cannone M, Marziliano N, Trimarco B, Guise
TA, et al: Calcium release channel RyR2 regulates insulin release
and glucose homeostasis. J Clin Invest. 125:43162015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prabhakar PK and Doble M: Mechanism of
action of natural products used in the treatment of diabetes
mellitus. Chin J Integr Med. 17:563–574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sullivan CS and Ganem D: MicroRNAs and
viral infection. Mol Cell. 20:3–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Staedel C and Darfeuille F: MicroRNAs and
bacterial infection. Cell Microbiol. 15:1496–1507. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kato M, Castro NE and Natarajan R:
MicroRNAs: potential mediators and biomarkers of diabetic
complications. Free Radic Biol Med. 64:85–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Filipowicz W: RNAi: The nuts and bolts of
the RISC machine. Cell. 122:17–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Latreille M, Hausser J, Stutzer I, Stützer
I, Zhang Q, Hastoy B, Gargani S, Kerr-Conte J, Pattou F, Zavolan M,
et al: MicroRNA-7a regulates pancreatic β cell function. J Clin
Invest. 124:2722–2735. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El Ouaamari A, Baroukh N, Martens GA,
Lebrun P, Pipeleers D and van Obberghen E: miR-375 targets
3′-phosphoinositide-dependent protein kinase-1 and regulates
glucose-induced biological responses in pancreatic beta-cells.
Diabetes. 57:2708–2717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lovis P, Gattesco S and Regazzi R:
Regulation of the expression of components of the exocytotic
machinery of insulin-secreting cells by microRNAs. Biol Chem.
389:305–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Correa-Medina M, Bravo-Egana V, Rosero S,
Ricordi C, Edlund H, Diez J and Pastori RL: MicroRNA miR-7 is
preferentially expressed in endocrine cells of the developing and
adult human pancreas. Gene Expr Patterns. 9:193–199. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Estep M, Armistead D, Hossain N, Elarainy
H, Goodman Z, Baranova A, Chandhoke V and Younossi ZM: Differential
expression of miRNAs in the visceral adipose tissue of patients
with non-alcoholic fatty liver disease. Aliment Pharmacol Ther.
32:487–497. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo H, Zhang H, Zhang Z, Zhang X, Ning B,
Guo J, Nie N, Liu B and Wu X: Down-regulated miR-9 and miR-433 in
human gastric carcinoma. J Exp Clin Cancer Res. 28:822009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chavali V, Tyagi SC and Mishra PK:
Differential expression of dicer, miRNAs, and inflammatory markers
in diabetic Ins2+/− Akita hearts. Cell Biochem Biophys. 68:25–35.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jansen F, Wang H, Przybilla D, Franklin
BS, Dolf A, Pfeifer P, Schmitz T, Flender A, Endl E, Nickenig G and
Werner N: Vascular endothelial microparticles-incorporated
microRNAs are altered in patients with diabetes mellitus.
Cardiovasc Diabetol. 15:492016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang JM and Zhang K: Microarray analysis
of microRNA expression in bone marrow-derived progenitor cells from
mice with type 2 diabetes. Genom Data. 7:86–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weir GC and Bonner-Weir S: Five stages of
evolving beta-cell dysfunction during progression to diabetes.
Diabetes. 53:(Suppl 3). S16–S21. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu X, Zhu Y, Liang Z, Li S, Xu X, Wang X,
Wu J, Hu Z, Meng S, Liu B, et al: c-Met and CREB1 are involved in
miR-433-mediated inhibition of the epithelial-mesenchymal
transition in bladder cancer by regulating Akt/GSK-3β/Snail
signaling. Cell Death Dis. 7:e20882016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang XC, Ma Y, Meng PS, Han JL, Yu HY and
Bi LJ: miR-433 inhibits oral squamous cell carcinoma (OSCC) cell
growth and metastasis by targeting HDAC6. Oral Oncol. 51:674–682.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu D, Zhang L, Cheng L, Ren L, Tang J and
Sun D: Pancreatic kininogenase ameliorates renal fibrosis in
streptozotocin induced-diabetic nephropathy rat. Kidney Blood Press
Res. 41:9–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gotanda K, Hirota T, Matsumoto N and Ieiri
I: MicroRNA-433 negatively regulates the expression of thymidylate
synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa
cells. BMC Cancer. 13:3692013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Greenhough A, Smartt HJ, Moore AE, Roberts
HR, Williams AC, Paraskeva C and Kaidi A: The COX-2/PGE2 pathway:
Key roles in the hallmarks of cancer and adaptation to the tumour
microenvironment. Carcinogenesis. 30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papadimitriou A, King AJ, Jones PM and
Persaud SJ: Anti-apoptotic effects of arachidonic acid and
prostaglandin E2 in pancreatic beta-cells. Cell Physiol Biochem.
20:607–616. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Burke SJ, Karlstad MD, Regal KM, Sparer
TE, Lu D, Elks CM, Grant RW, Stephens JM, Burk DH and Collier JJ:
CCL20 is elevated during obesity and differentially regulated by
NF-κB subunits in pancreatic β-cells. Biochim Biophys Acta.
1849:637–652. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tabriz HM, Mirzaalizadeh M, Gooran S, Niki
F and Jabri M: COX-2 expression in renal cell carcinoma and
correlations with tumor grade, stage and patient prognosis. Asian
Pac J Cancer Prev. 17:535–538. 2016. View Article : Google Scholar : PubMed/NCBI
|
